Matrix metalloproteinase‑1 expression in breast cancer and cancer‑adjacent tissues by immunohistochemical staining
- Authors:
- Jiajia Xuan
- Yunfeng Zhang
- Xiujun Zhang
- Fen Hu
View Affiliations
Affiliations: College of Life Sciences, Hebei United University, Tangshan, Hebei 063000, P.R. China, Department of Life Sciences, Tangshan Normal University, Tangshan, Hebei 063000, P.R. China, College of Psycology, Hebei United University, Tangshan, Hebei 063000, P.R. China
- Published online on: January 27, 2015 https://doi.org/10.3892/br.2015.420
-
Pages:
395-397
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Although matrix metalloproteinase‑1 (MMP‑1) has been considered a factor of crucial importance for breast cancer cells invasion and metastasis, the expression of MMP‑1 in different breast cancer and cancer‑adjacent tissues have not been fully examined. In the present study, immunohistochemical staining was used to detect the MMP‑1 expression in non‑specific invasive ductal carcinoma of the breast, cancer‑adjacent normal breast tissue, lymph node metastatic non‑specific invasive ductal carcinoma of the breast and normal lymph node tissue. The results showed that MMP‑1 expression is different in the above tissues. MMP‑1 had a positive expression in normal lymph node tissue and lymph node metastatic non‑specific invasive ductal carcinoma. The MMP‑1 negative expression rate was only 6.1% in non‑specific invasive ductal carcinoma of the breast and 2.9% in cancer‑adjacent normal breast tissue respectively. MMP‑1 expression is higher in non‑specific invasive ductal carcinoma and lymph node metastatic non‑specific invasive ductal carcinoma compared to cancer‑adjacent normal breast tissue and normal lymph node tissue. In conclusion, higher expression of MMP‑1 in breast cancer may play a crucial role in promoting breast cancer metastasis.
View References
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Rugo HS: The importance of distant
metastases in hormone-sensitive breast cancer. Breast. 17 (Suppl
1):S3–S8. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Nagaiah G and Abraham J: Circulating tumor
cells in the management of breast cancer. Clin Breast Cancer.
10:209–216. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chabottaux V and Noel A: Breast cancer
progression: insights into multifaceted matrix metalloproteinases.
Clin Exp Metastasis. 24:647–656. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Liu H, Kato Y, Erzinger SA, et al: The
role of MMP-1 in breast cancer growth and metastasis to the brain
in a xenograft model. BMC Cancer. 12:5832012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hu F, Wang C, Guo S, et al: δEF1 promotes
osteolytic metastasis of MDA-MB-231 breast cancer cells by
regulating MMP-1 expression. Biochim Biophys Acta. 1809:200–210.
2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kang Y, Siegel PM, Shu W, et al: A
multigenic program mediating breast cancer metastasis to bone.
Cancer Cell. 3:537–549. 2003. View Article : Google Scholar : PubMed/NCBI
|